Elicera Therapeutics AB (publ) (FRA:8E8)
Germany · Delayed Price · Currency is EUR 0.4945
-0.0035 (-0.70%)
Jan 29, 2026, 10:00 AM EST
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of €24.65 million as of January 30, 2026. Its market cap has increased by 214.80% in one year.
Market Cap
24.65M
Enterprise Value
21.33M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.49
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 12.18M to 24.65M, an increase of 102.35%. That is a compound annual growth rate of 16.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 24.65M | 5.18% |
| Dec 30, 2025 | 23.43M | 358.22% |
| Dec 30, 2024 | 5.11M | -36.80% |
| Dec 29, 2023 | 8.09M | 29.64% |
| Dec 30, 2022 | 6.24M | -35.63% |
| Dec 30, 2021 | 9.70M | -20.40% |
| Jun 11, 2021 | 12.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.08M |
| Biomark Diagnostics | 28.58M |
| Rubean AG | 27.29M |
| Hyrican Informationssysteme Aktiengesellschaft | 22.80M |
| Petro Matad | 22.31M |
| ACCENTRO Real Estate AG | 21.00M |
| Pearl Gold AG | 18.75M |